In conclusion, the present study with up to 14.4-year follow-up shows that strong Tiam1 overexpression in prostate cancer relative to the corresponding benign prostate epithelial cells correlates with aggressive disease and is an independent prognostic indicator of disease recurrence. This evidence concerns the gene TIAM1 and prostate carcinoma.